Global Wound Care Market Outlook 2030

  • Product Code:
  • Published Date:
    14 Sep 2021
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More


Market Overview:

In 2021, the global wound care market is likely to be worth USD 20 billion and is expected to grow at a compound annual growth rate (CAGR) of 5% from 2022 to 2030. Due to the growing demand for wound care products, the elderly population; the high prevalence of chronic diseases such as diabetes, cancer and other autoimmune diseases; and the increasing number of outpatient surgery centers (ASC) around the world. Unhealthy and sedentary lifestyles, heavy drinking and smoking are some of the main factors contributing to the increase in the prevalence of non-communicable diseases. According to the 2017 National Diabetes Statistics Report released by the Centers for Disease Control and Prevention (CDC), more than 100 million people in the United States have diabetes or pre-diabetes.

Cancer also represents a global health burden because it is one of the leading causes of death. According to estimates by the World Health Organization, almost 1 in 6 people is caused by this disease. In addition, they report that more than 70% of cancer-related deaths usually occur in low-income countries.

Due to the increase in the prevalence of chronic diseases, the number of operations performed has also increased, which is why wound care products are increasingly used to prevent infections at the surgical site. Most surgical wounds after cancer surgery are relatively large and deep, and produce exudate that requires regular treatment. Wound care products, such as Negative Pressure Wound Therapy (NPWT) devices, sutures and staples, help treat large wounds and significantly reduce the risk of infection. It is expected to drive market growth.

For example, according to WHO estimates (2018), in India, about 1,000,000 people suffer severe or moderate burns every year. In addition, according to the NCBI report, the incidence of burns reported in Bulgaria, Finland, the Netherlands, China, Australia, and the United Kingdom increased in 2017. Used to treat acute wounds. Papain-based products are not usually used for burn wounds, but in some cases, they are used for superficial and minor burns. Therefore, it is expected that more and more accidents will drive the demand for enzymatic wound debridement products, which in turn will drive market growth during the forecast period.


The advanced product segment will have the largest revenue share in 2020, exceeding 33%, and will grow at the fastest compound annual growth rate in the forecast year. Advanced wound dressings are mainly used to treat non-healing and chronic wounds. Some of these products contain antibacterial agents, such as honey and silver, which are used to fast wound healing and prevent new infections.

The limitations of traditional wound dressings are driving the growth of the advanced wound care market. In addition, the increase in diabetes cases is expected to drive the growth of this market segment during the forecast period. For example, according to the Centers for Disease Control and Prevention (CDC), in 2015, approximately 9.40% of the population of all ages in the United States had diabetes. Advanced products are subdivided into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, etc.

It is estimated that due to the increase in the number of surgeries, the surgical product segment will achieve the second fastest compound annual growth rate between 2021 and 2028. This part is further subdivided into sutures and staples, tissue adhesives and sealants, and anti-infective dressings. The suture and staple segment used to have the largest market share.


The acute wounds sector has the largest revenue share in 2020, at 58%, and will further expand at a constant compound annual growth rate from 2022-2030. Acute wounds include surgical and trauma wounds and burns. Due to the increase in trauma cases worldwide, surgical and traumatic injuries are the leading market segments in terms of growth rate and revenue share.

The chronic wound care segment is expected to show the fastest growth rate during the forecast period. The increase in cases of chronic diseases (especially diabetes) and the increase in the global elderly population are the main factors driving the growth of this market segment. For example, according to the U.S. Census Bureau, between 2014 and 2015, the number of people aged 65 and over increased by 1.6 million. This part is further divided into diabetic foot ulcers, pressure ulcers, and lower limb venous ulcers.


In 2020, the hospital end-use department has the largest revenue share, exceeding 40%. NPWT and surgical wound care dressings are mainly suitable for hospital use, not for home care. NPWT requires long-term hospitalization and continuous monitoring. The increase in cases of diabetic foot ulcers and venous ulcers of the lower extremities is the main driver of segmental growth because NPWT is mainly used for these diseases.

It is expected that during the forecast period, the growth rate of the home healthcare sector will be the highest. Wound care in the home care environment mainly started with the introduction of a disposable NPWT system. These devices are lightweight, portable, containerless, and easy to use. In addition, the cost-effectiveness of such therapies encourages patients to adopt home care environments during hospitalization, thereby supporting the growth of market segments.


North America is the largest regional market in 2020 and will further expand to a significant compound annual growth rate from 2021 to 2030 due to increased sports injury cases, road accidents and the presence of several major companies in the region. In addition, the availability of qualified professionals and improvements in medical infrastructure are expected to drive the market during the forecast period.

Due to the rapid growth of medical tourism in emerging countries such as China, India, and Japan, the Asia-Pacific region is expected to become the fastest-growing regional market from 2021 to 2030. For example, according to the report of the General Administration of Business Intelligence and Statistics of India on the export of medical services, there were 58,300 medical tourists holding medical visas in India from 2015 to 2016.


Major players are adopting mergers and acquisitions and cooperation strategies to strengthen their position in the market. For example, in April 2019, Smith & Nephew PLC acquired Osiris Therapeutics, Inc. to accelerate the development of its advanced wound care product portfolio. The plan is expected to expand its customer base. Some of the major players in the global wound care market include:

Smith & Nephew PLC,Mölnlycke Health Care AB, Acelity (KCI Licensing, Inc.), ConvaTec Group PLC, Ethicon Inc. (Johnson & Johnson), Baxter International, Inc., Coloplast Corp., Medtronic PLC, The 3M Company, Derma Sciences, Inc. (Integra LifeSciences), Medline Industries, Inc., Advancis Medical USA LLC, B. Braun Melsungen AG.


This report predicts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global wound care market based on product, end use, application and region: Product Outlook (Revenue, USD Million, 2022-2030) Advanced Wound Dressing Foam Dressing Dressing Hydrocolloid Film Dressing Alginate Dressing Hydrogel Dressing Collagen Dressing Other Advanced Dressing Surgical Wound Care Sutures and Staples Anti-infective Dressing Traditional Wound Care Medical Tape Cleaner Wound Treatment Equipment NPWTO Hyperbaric Oxygen and Oxygen Equipment Electrical Stimulation Equipment Pressure Release Equipment Other Wounds Ultimate Purpose (income, millions of dollars, 2022-2030) 8) Chronic wounds, diabetic foot ulcers, pressure sores, venous ulcers of the lower extremities, other chronic wounds, acute injury surgery and traumatic burns.


Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook



1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions


3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5.1 Chronic Wounds
5.1.1 Diabetic Foot Ulcers (DFUS)
5.1.2 Pressure Ulcers
5.1.3 Venous Leg Ulcers
5.1.4 Others

5.2 Acute Wounds
5.2.1 Surgical & Traumatic Wounds
5.2.2 Burns

6.1 Advanced wound management products

6.1.1 Advanced Wound Dressings Foam Dressings Hydrocolloid Dressings Film Dressings Alginate Dressings Hydrogel Dressings Collagen Dressings Other Advanced Dressings

6.1.2 Wound Therapy Devices Pressure Relief Devices Negative Pressure Wound Therapy (NPWT) Systems Oxygen and Hyperbaric Oxygen Equipment Electrical Stimulation Devices

6.1.3 Active Wound Care Products Artificial Skin and Skin Substitutes Topical Agents

6.2 Surgical Wound Care Products

6.2.1 Sutures and Staples

6.2.2 Tissue Adhesives, Sealants, and Glues Fibrin-Based Sealants Collagen-Based Sealants Synthetic Adhesives/Glues

6.3 Anti-Infective Dressings

6.4 Traditional Wound Care Products
6.4.1 Medical Tapes
6.4.2 Dressings
6.4.3 Cleansing Agents

7.1 Hospitals & Specialty Wound Care Clinics
7.2 Inpatient Settings
7.3 Outpatient Settings
7.4 Long-Term Care Facilities
7.5 Home Healthcare

8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 – 2025

9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10.1 Smith & Nephew PLC
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Mölnlycke Health Care AB
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Acelity L.P. Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Convatec Group PLC
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Ethicon Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Baxter International Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Coloplast A/S
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Medtronic PLC
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 3M Company
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Derma Sciences, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

11 Appendix
11.1 Related Reports

Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports